MIT/CRE Welcomes Merck as New Industry Partner
The MIT/CRE is thrilled to announce a new partner to our Industry Partnership Program: Merck!
Merck is an innovative, global healthcare leader with a 125-year history that is committed to improving health and wellbeing around the world. Corporate responsibility is at the heart of the company’s mission to discover, develop and provide innovative products and services that save and improve lives. Their core product categories include diabetes, cancer, vaccines and hospital acute care. They continue to focus their research on conditions that represent some of today’s most significant health challenges – like cancer, HIV, HPV, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer’s disease, and they are on the front lines in the fight against emerging global pandemics, such as Ebola.
Headquartered in Kenilworth, NJ and with over 71,000 employees, Merck operates in more than 140 countries.